Aldeyra Therapeutics Inc (ALDX)
4.165
+0.04
(+1.09%)
USD |
NASDAQ |
May 07, 16:00
4.165
0.00 (0.00%)
After-Hours: 17:15
Aldeyra Therapeutics Net Income (TTM): -30.01M for March 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -30.01M |
December 31, 2023 | -37.54M |
September 30, 2023 | -45.69M |
June 30, 2023 | -52.06M |
March 31, 2023 | -60.85M |
December 31, 2022 | -62.02M |
September 30, 2022 | -64.88M |
June 30, 2022 | -66.12M |
March 31, 2022 | -63.27M |
December 31, 2021 | -57.78M |
September 30, 2021 | -53.31M |
June 30, 2021 | -46.39M |
March 31, 2021 | -38.98M |
December 31, 2020 | -37.55M |
September 30, 2020 | -39.42M |
June 30, 2020 | -49.26M |
March 31, 2020 | -55.07M |
December 31, 2019 | -60.83M |
September 30, 2019 | -58.30M |
June 30, 2019 | -50.40M |
March 31, 2019 | -46.12M |
December 31, 2018 | -38.89M |
Date | Value |
---|---|
September 30, 2018 | -35.21M |
June 30, 2018 | -29.39M |
March 31, 2018 | -25.65M |
December 31, 2017 | -22.34M |
September 30, 2017 | -20.04M |
June 30, 2017 | -19.83M |
March 31, 2017 | -18.82M |
December 31, 2016 | -18.70M |
September 30, 2016 | -18.40M |
June 30, 2016 | -16.99M |
March 31, 2016 | -14.92M |
December 31, 2015 | -12.09M |
September 30, 2015 | -10.18M |
June 30, 2015 | -8.823M |
March 31, 2015 | -7.726M |
December 31, 2014 | -5.187M |
September 30, 2014 | 6.553M |
June 30, 2014 | 17.87M |
March 31, 2014 | 17.44M |
December 31, 2013 | 13.06M |
September 30, 2013 | -17.98M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-66.12M
Minimum
Jun 2022
-30.01M
Maximum
Mar 2024
-51.49M
Average
-52.69M
Median
Net Income (TTM) Benchmarks
AbbVie Inc | 5.993B |
United Therapeutics Corp | 1.050B |
Heron Therapeutics Inc | -110.56M |
Esperion Therapeutics Inc | -209.25M |
FibroGen Inc | -284.23M |